Cipla LtdPharmaceuticalsINE059A01026Consolidated₹1394.50+18.20 (+1.32%)Jun-26
Valuation
Market Cap₹1.13L Cr
TTM PE33.41x
Forward PE41.82x
PEG-2.55
Book Value₹426.22
P/B3.27x
TTM EPS₹41.74
Fwd EPS₹33.35
TTM Revenue₹28.32K Cr
TTM PAT₹3.36K Cr
TTM EBITDA₹5.30K Cr
TTM EBIT₹4.03K Cr
Last Qtr PAT₹785.55 Cr
Last Qtr EBITDA₹1.19K Cr
Last Qtr EBIT₹888.06 Cr
Profitability
ROE9.75%
ROCE13.11%
TTM NPM11.85%
TTM EBITDA %18.70%
Curr OPM10.72%
Last OPM8.11%
Curr NPM—
Last NPM—
Curr EPS₹9.77
Last EPS₹6.87
Balance sheet
Equity₹161.56 Cr
Reserve₹34.27K Cr
Total Debt₹613.77 Cr
D/E0.02x
Interest %2.17%
Curr Interest₹17.03 Cr
Price / range
Close₹1394.50
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+1.32%
1W+2.09%
1M-2.56%
3M+2.88%
6M+9.96%
1Y-11.65%
2Y-15.58%
3Y+12.42%
5Y+46.17%
Diwali-7.04%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits